Monkeypox emergency: Urgent questions and perspectives
- PMID: 35998628
- PMCID: PMC9395144
- DOI: 10.1016/j.cell.2022.08.002
Monkeypox emergency: Urgent questions and perspectives
Abstract
Amidst the COVID-19 pandemic, we now face another public health emergency in the form of monkeypox virus. As of August 1, the Centers for Disease Control and Prevention report over 23,000 cases in 80 countries. An inclusive and global collaborative effort to understand the biology, evolution, and spread of the virus as well as commitment to vaccine equity will be critical toward containing this outbreak. We share the voices of leading experts in this space on what they see as the most pressing questions and directions for the community.
Copyright © 2022. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests S.L.S. is a founder of Darwin Biosciences and a member of its scientific advisory board. She serves as a consultant for the MITRE Corp. and as a senior editor at the journal eLife. She is a member of the Planning Committee for Countering Zoonotic Spillover of High Consequence Pathogens, sponsored by the Academies of Sciences, Engineering, and Medicine. B.T. has received consulting fees for the non-profit organization CRITICA for work unrelated to the present publication.
Figures
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
